BRACE PHARMA
Brace Pharma Capital is a strategic investment company formed by EMS S/A, the largest pharmaceutical company in Brazil, and high net worth biotech investors. We invest in innovative, life changing therapies for diseases with a high degree of unmet medical need and insufficient treatment options.
BRACE PHARMA
Social Links:
Industry:
Biotechnology
Founded:
2013-01-01
Status:
Active
Contact:
(240)403-7153
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Google Apps For Business Unified Layer CKEditor Endurance Page Cache Rackspace Email Hosting HostGator DNS Tiny MCE Tailwind CSS
Similar Organizations
Clarus Ventures
Clarus Ventures is a Massachusetts-based venture capital firm focused on investments in the healthcare sector.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-11-02 | Antiva Biosciences | Brace Pharma investment in Series D - Antiva Biosciences | 31 M USD |
| 2021-07-14 | Turnstone Biologics | Brace Pharma investment in Series D - Turnstone Biologics | 80 M USD |
| 2021-02-11 | Pipeline Therapeutics | Brace Pharma investment in Series C - Pipeline Therapeutics | 80 M USD |
| 2020-08-25 | ReViral | Brace Pharma investment in Series C - ReViral | 44 M USD |
| 2020-08-12 | F2G | Brace Pharma investment in Private Equity Round - F2G | 60.8 M USD |
| 2020-05-21 | HotSpot Therapeutics | Brace Pharma investment in Series B - HotSpot Therapeutics | 65 M USD |
| 2019-12-18 | Pipeline Therapeutics | Brace Pharma investment in Series B - Pipeline Therapeutics | 32 M USD |
| 2019-11-13 | Avidity Biosciences | Brace Pharma investment in Series C - Avidity Biosciences | 100 M USD |
| 2018-10-17 | Avidity Biosciences | Brace Pharma investment in Series B - Avidity Biosciences | 16 M USD |
| 2018-08-01 | ReViral | Brace Pharma investment in Series B - ReViral | 55 M USD |